# Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina

> **NCT01549977** · PHASE2 · TERMINATED · sponsor: **Takeda** · enrollment: 1 (actual)

## Conditions studied

- Angina

## Interventions

- **DRUG:** Febuxostat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01549977
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Business Decision (please see below)
- **Last updated:** 2013-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01549977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01549977, "Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01549977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*